Skip to main content

BARCLAYS PLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 312069 LONDON, X0

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,319,201
+$515,594 QoQ
Shares Held
166,566
+20.2% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 238 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. XERS ranks #21 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,319,201 166,566
2026-03-31 $803,607 138,553
2025-12-31 $2,847,594 362,751
2025-09-30 $2,821,641 346,639
2025-06-30 $1,981,237 424,248
2025-03-31 $1,540,685 280,635
2024-12-31 $1,178,506 347,642
2024-09-30 $924,744 324,472
2024-06-30 $388,770 172,787
2024-03-31 $452,990 204,973
2023-12-31 $648,513 275,963
2023-09-30 $196,681 105,743
2023-06-30 $242,881 92,703
2023-03-31 $227,763 139,732
2022-12-31 $144,053 108,311
2022-09-30 $94,762 60,745
2022-06-30 $45,574 29,594
2022-03-31 $55,777 21,788